Literature DB >> 20020363

Nandrolone: a multi-faceted doping agent.

Peter Hemmersbach1, Joachim Grosse.   

Abstract

Nandrolone or nortestosterone, an anabolic-androgenic steroid, has been prohibited by doping control regulations for more than 30 years. Although its main metabolism in the human body was already known at that time, and detection of its misuse by gas or liquid chromatographic separation with mass spectrometric detection is straightforward, many interesting aspects regarding this doping agent have appeared since.Over the years, nandrolone preparations have kept their position among the prohibited substances that are most frequently detected in WADA-accredited laboratories. Their forms of application range from injectable fatty acid esters to orally administered nandrolone prohormones. The long detection window for nandrolone ester preparations and the appearance of orally available nandrolone precursors have changed the pattern of misuse.At the same time, more refined analytical methods with lowered detection limits led to new insights into the pharmacology of nandrolone and revelation of its natural production in the body.Possible contamination of nutritional supplements with nandrolone precursors, interference of nandrolone metabolism by other drugs and rarely occurring critical changes during storage of urine samples have to be taken into consideration when interpreting an analytical finding.A set of strict identification criteria, including a threshold limit, is applied to judge correctly an analytical finding of nandrolone metabolites. The possible influence of interfering drugs, urine storage or natural production is taken into account by applying appropriate rules and regulations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20020363     DOI: 10.1007/978-3-540-79088-4_6

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  3 in total

1.  Implication of Human UGT2B7, 2B15, and 2B17 in 19-Norandrosterone Metabolism.

Authors:  Emmanuel Strahm; Ulf Sjöberg; Mats Garle; Anders Rane; Lena Ekström
Journal:  Front Endocrinol (Lausanne)       Date:  2013-06-26       Impact factor: 5.555

2.  Determination of DNA damage and telomerase activity in stanozolol-treated rats.

Authors:  Mehtap Kara; Eren Ozcagli; Persefoni Fragkiadaki; Tugba Kotil; Polychronis D Stivaktakis; Demetrios A Spandidos; Aristides M Tsatsakis; Buket Alpertunga
Journal:  Exp Ther Med       Date:  2016-12-15       Impact factor: 2.447

3.  Control of Anabolic Hormone Residues in Tissues of Slaughter Animals in Poland During the Period of 2011-2015.

Authors:  Matraszek-Żuchowska Iwona; Woźniak Barbara; Kłopot Alicja; Witek Sebastian; Sielska Katarzyna; Posyniak Andrzej
Journal:  J Vet Res       Date:  2017-04-04       Impact factor: 1.744

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.